Bevantolol

Bevantolol is a beta blocker used in the treatment of hypertension and angina pectoris. It is a non-selective beta blocker that also has alpha-1 blocking activity.

Pharmacology[edit]

Bevantolol is a competitive antagonist at both beta-1 adrenergic receptors and beta-2 adrenergic receptors, providing non-selective beta blockade. It also has alpha-1 adrenergic receptor blocking activity which can result in vasodilation and decreased peripheral resistance.

Clinical Use[edit]

Bevantolol is used in the treatment of hypertension, a condition characterized by high blood pressure. It is also used in the management of angina pectoris, a type of chest pain caused by reduced blood flow to the heart.

Side Effects[edit]

Common side effects of Bevantolol include fatigue, dizziness, and shortness of breath. Less common side effects can include depression, sleep disturbances, and sexual dysfunction.

Contraindications[edit]

Bevantolol is contraindicated in patients with bronchial asthma, sinus bradycardia, second and third degree heart block, overt cardiac failure, and cardiogenic shock.

Drug Interactions[edit]

Bevantolol can interact with other medications, including other beta blockers, calcium channel blockers, and digoxin.